These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32986099)

  • 21. Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
    Wang Y; Yang C; Song Y; Coleman JR; Stawowczyk M; Tafrova J; Tasker S; Boltz D; Baker R; Garcia L; Seale O; Kushnir A; Wimmer E; Mueller S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34193524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The Saga of Vaccines against Covid-19].
    Saliou P
    Bull Soc Pathol Exot; 2020; 113(4):185-186. PubMed ID: 33826275
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 vaccine exclusion based on legal residence is unwise and unethical.
    Lee LM; Lowe AE; Wynia MK
    J Public Health Policy; 2021 Jun; 42(2):346-349. PubMed ID: 33941847
    [No Abstract]   [Full Text] [Related]  

  • 24. COVID-19 Vaccine: Practical Clinical Considerations.
    Laine C; Cotton D; Moyer DV
    Ann Intern Med; 2021 May; 174(5):694. PubMed ID: 33769829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces.
    Perosa F; Favoino E; Prete M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(4):567-568. PubMed ID: 33290205
    [No Abstract]   [Full Text] [Related]  

  • 26. Targets and strategies for vaccine development against SARS-CoV-2.
    Malik JA; Mulla AH; Farooqi T; Pottoo FH; Anwar S; Rengasamy KRR
    Biomed Pharmacother; 2021 May; 137():111254. PubMed ID: 33550049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovators target vaccines for variants and shortages in global South.
    Sheridan C
    Nat Biotechnol; 2021 Apr; 39(4):393-396. PubMed ID: 33731936
    [No Abstract]   [Full Text] [Related]  

  • 28. COVID-19 Vaccines: Current Status and Implication for Use in Indonesia.
    Ophinni Y; Hasibuan AS; Widhani A; Maria S; Koesnoe S; Yunihastuti E; Karjadi TH; Rengganis I; Djauzi S
    Acta Med Indones; 2020 Oct; 52(4):388-412. PubMed ID: 33377885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure to achieve global vaccine equity will have dire consequences.
    Goldstein A
    BMJ; 2021 Mar; 372():n712. PubMed ID: 33741580
    [No Abstract]   [Full Text] [Related]  

  • 30. Africa's need for more COVID-19 clinical trials.
    Makoni M
    Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137
    [No Abstract]   [Full Text] [Related]  

  • 31. Status of vaccine development for COVID-19.
    Mendes A
    Br J Community Nurs; 2020 Dec; 25(12):620-621. PubMed ID: 33275511
    [No Abstract]   [Full Text] [Related]  

  • 32. Italian association for the study of the liver position statement on SARS-CoV2 vaccination.
    Russo FP; Piano S; Bruno R; Burra P; Puoti M; Masarone M; Montagnese S; Ponziani FR; Petta S; Aghemo A;
    Dig Liver Dis; 2021 Jun; 53(6):677-681. PubMed ID: 33941488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
    Walsh EE; Frenck RW; Falsey AR; Kitchin N; Absalon J; Gurtman A; Lockhart S; Neuzil K; Mulligan MJ; Bailey R; Swanson KA; Li P; Koury K; Kalina W; Cooper D; Fontes-Garfias C; Shi PY; Türeci Ö; Tompkins KR; Lyke KE; Raabe V; Dormitzer PR; Jansen KU; Şahin U; Gruber WC
    N Engl J Med; 2020 Dec; 383(25):2439-2450. PubMed ID: 33053279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward.
    Iserson KV
    Camb Q Healthc Ethics; 2021 Jan; 30(1):59-68. PubMed ID: 32498742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
    Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
    Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blunted humoral response after mRNA vaccine in patients with haematological malignancies.
    Kamboj M
    Lancet Haematol; 2021 Aug; 8(8):e540-e542. PubMed ID: 34224666
    [No Abstract]   [Full Text] [Related]  

  • 37. Testing vaccines in the time of Covid: The changing landscape.
    Cash RA
    Indian J Med Ethics; 2021; VI(2):1-4. PubMed ID: 33908357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults.
    Fisher KA; Bloomstone SJ; Walder J; Crawford S; Fouayzi H; Mazor KM
    Ann Intern Med; 2020 Dec; 173(12):964-973. PubMed ID: 32886525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.